Associate Director, Data Management at Rainier Therapeutics - San Leandro, California, United States
Rainier Therapeutics is a privately-held biotechnology developing biologics to address medical conditions where there is significant unmet need.Our lead program is a human monoclonal antibody, B-701, that targets and blocks the activity of FGFR3 (fibroblast growth factor receptor 3) and is the most advanced FGFR3-specific antagonist in development.